Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Immatics N.V. (IMTXW)

  • Business News
  • Dec. 05, 2025, 11:01 UTC
  • 15
  • 1 comments

Immatics Announces $125 Million Underwritten Offering

Market reaction Comment Full text

OrganiGram Holdings Inc (OGI)

  • Business News
  • Dec. 05, 2025, 11:00 UTC
  • 13
  • 1 comments

Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025

Market reaction Comment Full text

Immatics N.V. (IMTX)

  • Business News
  • Dec. 05, 2025, 11:00 UTC
  • 12
  • 1 comments

Immatics Announces $125 Million Underwritten Offering

Market reaction Comment Full text

ORIC Pharmaceuticals Inc (ORIC)

  • Business News
  • Dec. 05, 2025, 06:00 UTC
  • 15
  • 1 comments

ORIC® Pharmaceuticals Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 05, 2025, 03:23 UTC
  • 18
  • 1 comments

How Does The NVIDIA GeForce RTX 3090 Perform In 2026?

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 05, 2025, 03:19 UTC
  • 17
  • 1 comments

The Latest About Sea of Thieves: Season 18 and Exciting New Updates

Market reaction Comment Full text

Protara Therapeutics Inc. (TARA)

  • Business News
  • Dec. 05, 2025, 03:03 UTC
  • 14
  • 1 comments

Protara Announces Pricing of $75 Million Public Offering

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 05, 2025, 02:50 UTC
  • 17
  • 1 comments

How to Use Uniswap: A Step-by-Step Guide

Market reaction Comment Full text

ORIC Pharmaceuticals Inc (ORIC)

  • Business News
  • Dec. 05, 2025, 02:45 UTC
  • 17
  • 1 comments

ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and Previously Treated NSCLC Patients with EGFR Atypical Mutations at the ESMO Asia Congress 2025

Market reaction Comment Full text

Aoxin Q & M Dental Grp Limited (1D4)

  • Business News
  • Dec. 05, 2025, 02:08 UTC
  • 17
  • 1 comments

Q & M Dental Group (Singapore) Limited - Announcement

Market reaction Comment Full text
  • Previous
  • 411
  • 412
  • 413
  • 414
  • 415
  • Next

Search

News categories

  • Technical Exchange News(10917)
  • Event(2337)
  • SEC News(190706)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124969)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin